Intended for Healthcare Professionals
New SURGIFLO™ is now faster, simpler and more consistent to prepare
Johnson & Johnson, a global leader in surgical technologies and solutions, has launched new SURGIFLO™ Hemostatic Matrix Kit with Thrombin, which delivers the same trusted efficacy1* as the current SURGIFLO™, but now with an unbeatable preparation time.1†
SURGIFLO™ is a flowable, gelatin-based hemostatic matrix used in surgical procedures to stop bleeding. It is particularly effective in difficult-to-access bleeding2-8, where surgeons are faced with challenges including limited visibility or an uneven bleeding surface.
Like all flowable hemostats, SURGIFLO™ must be mixed and prepared in the operating room (OR) before use. Time is of the essence, and any preparation delays can be associated with increased stress. SURGIFLO™ now delivers the same trusted efficacy with faster, simpler and more consistent preparation1*, making it 36% faster than the current SURGIFLO™1* and more than 2.5 times faster than a leading competitor.1±
“We are delighted to support surgeons and patients across the EMEA region with our new SURGIFLO™ Hemostatic Matrix Kit with Thrombin,” said Francois Gaudemet, President, Surgery EMEA. “When there’s an urgent bleed in the operating room, surgeons need a hemostat immediately, and any delay can be stressful. New SURGIFLO™ is a fast and effective way to control blood loss.”
New SURGIFLO also uses less components and has a lower environmental impact.1§
*Based participants feedback to SURGIFLO™ MS0016 Non-Clinical Product Claims.
Compared to SURGIFLO™ MS0012 Haemostatic Matrix Kit with Thrombin and Floseal Haemostatic Matrix 5 ml
†Compared to SURGIFLO™ Hemostatic Matrix Kit with Thrombin (MS0012) and Floseal
Haemostatic Matrix 5 ml
‡Compared to SURGIFLO™(MS0012)
±Compared to Floseal Haemostatic Matrix 5 ml
§Compared to SURGIFLO™ Hemostatic Matrix Kit with Thrombin (MS0012) and Floseal Haemostatic Matrix 5 ml
References
- Ferrosan Medical Devices.Time Motion Study Report MS0016.9/02/2026
- Surgiflo TM Haemostatic Matrix Instructions for use 2022; 4548686 ;MS0010
- Surgiflo TM Haemostatic Matrix With Thrombin Instructions for use 2022; 4548699; MS0012
- Gazzeri R, Galarza M, Alex AThe Saftey and Biocompatibility Of
- Gelatin Hemostatic Matrix (Floseal and Surgiflo) In Neurosurgical Procedures; 2012; SFL-183-12
- G.Buiret, M.Pavic, J.C.Pignat and F.Pasquet Gelatin Thrombin Matrix:
- A New and Simple Way to Manage Recurrent Expistaxis in Hematology Units 2013; 10.1155; 851270
- E.Cantone; American Journal of Emergency Medicine 2014; 0735-6757
©Johnson and Johnson and its affiliates 2026. M_EM_SRG_BIOS_417334
The third-party trademarks used herein are the trademarks of their respective owners.
Important Information: Please refer to the latest Instructions for Use and/or Package Insert provided by the manufacturer of the device for the details such as indications, contraindications, side effects, warnings, and precautions.
You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.